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Letter to the Editor: Measurement of V̇O2max in clinical groups is feasible and 4 
necessary. 5 
Response to: Measurement of the maximum oxygen uptake V̇O2max: V̇O2peak is no longer 6 
acceptable  7 
(Poole and Jones, J Appl Physiol, 122: 997 – 1002) 8 
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We commend the recent CORP statement by Poole and Jones (1) where they advocate the use 35 
of a supramaximal bout to verify maximal oxygen uptake (V̇O2max) obtained during 36 
incremental exercise. The authors cite research that supports this approach, particularly in 37 
clinical populations, where exercise testing provides important prognostic information, such 38 
as individuals with cystic fibrosis (CF). 39 
 40 
However, subsequent correspondence from van Breda et al. (3) concluded that ‘the short 41 
constant-work rate verification phase after the steep-ramp test…is, at least in a clinical 42 
setting, unrealistic and unethical in certain patient populations’ (pp. 1370). We disagree with 43 
this statement, as evidence has consistently shown that a verification phase is crucial if 44 
clinicians are to have confidence in the determination of V̇O2max. In paediatric patients with 45 
CF, we have shown that a further increase in V̇O2 can be elicited by performing 46 
supramaximal verification (2), which also improves test-retest reliability and eliminates 47 
dependence on secondary criteria (heart rate, respiratory exchange ratio, blood lactate etc.). 48 
Our group has been utilising cardiopulmonary exercise testing (CPET) with supramaximal 49 
verification in our routine adult and paediatric clinical practice for over five years. It is 50 
included in our portfolio of annual review investigations and we have performed 110 in the 51 
last 2 years. We are aware that the two-stage protocol is preferred in a further three UK CF 52 
Centres, and others have expressed interest in adopting the same methodology. The 53 
supramaximal protocol is affordable, accepted by patients and most importantly safe when 54 
performed correctly. We have not had any adverse events with any of our CPET testing 55 
across a full range of clinical severity. 56 
 57 
Given the prognostic value of V̇O2max, being able to discriminate between ‘day-to-day 58 
variation’ and clinically meaningful changes, due to disease progression and/or therapeutic 59 
intervention, is essential. Indeed, previous clinical studies have suggested their own 60 
conclusions may be limited by the lack of supramaximal verification testing, highlighting the 61 
need to heed the advice presented in the CORP statement (1). 62 
 63 
We agree with van Breda et al. (3) that “the concepts of aerobic/anaerobic and ventilatory 64 
thresholds encompass important clinical information”. However, it should be noted such 65 
parameters should be normalised to a percentage of V̇O2max, which therefore warrants 66 
accurate determination. 67 
 68 
In clinical practice, tracking changes in aerobic capacity over time will have more precision 69 
and meaning if the most accurate methodology is used. It is for this very reason that our 70 
group and associated clinical teams fully support the methodological recommendation of 71 
utilising supramaximal verification as part of CPET.  72 
 73 
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